These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3965496)

  • 1. Non-specific binding of mouse IgM antibodies to lipid antigens.
    Hofstetter W; Heusser CH; Blaser K
    J Neuroimmunol; 1985 Jan; 7(4):207-14. PubMed ID: 3965496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and biological properties of a monoclonal antibody to galactocerebroside.
    Rostami A; Eccleston PA; Silberberg DH; Hirayama M; Lisak RP; Pleasure DE; Phillips SM
    Brain Res; 1984 Apr; 298(2):203-8. PubMed ID: 6202367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of high titer antibodies to galactocerebroside.
    Benjamins JA; Callahan RE; Montgomery IN; Studzinski DM; Dyer CA
    J Neuroimmunol; 1987 Apr; 14(3):325-38. PubMed ID: 3558790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of mouse antibodies against the brain lipid sulfatide.
    Hofstetter W; Heusser CH; Herschkowitz N; Blaser K
    J Immunol Methods; 1983 Feb; 57(1-3):99-109. PubMed ID: 6827115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural study of central nervous system demyelination in galactocerebroside sensitized rabbits.
    Goban Y; Saida T; Saida K; Nishitani H; Kameyama M
    Lab Invest; 1986 Jul; 55(1):86-90. PubMed ID: 3724066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody induced agglutination of galactocerebroside liposomes.
    Sarkar DP; Das PK; Das MK
    Indian J Exp Biol; 1982 Jul; 20(7):522-4. PubMed ID: 7173984
    [No Abstract]   [Full Text] [Related]  

  • 7. A new assay for lytic anti-galactocerebroside (GC) antibodies employing 56Rubidium release from GC-labelled liposomes.
    Slovick DI; Saida T; Lisak RP; Schreiber A
    J Immunol Methods; 1980; 39(1-2):31-8. PubMed ID: 7007512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector--target cell interaction of lymph node cells from galactocerebroside-sensitized rats with oligodendrocytes of brain cell cultures.
    Niedieck B; Lohmann U
    J Neuroimmunol; 1981 Jun; 1(2):191-4. PubMed ID: 6978351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-galactocerebroside antibodies in human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA).
    Ichioka T; Uobe K; Stoskopf M; Kishimoto Y; Tennekoon G; Tourtellotte WW
    Neurochem Res; 1988 Mar; 13(3):203-7. PubMed ID: 3133570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human alpha-fetoprotein-rich fraction inhibits galactocerebroside antibody-mediated lysis of oligodendrocytes in vitro.
    Lubetzki-Korn I; Hirayama M; Silberberg DH; Schreiber AD; Eccleston PA; Pleasure D; Brenner T; Abramsky O
    Ann Neurol; 1984 Feb; 15(2):171-80. PubMed ID: 6200057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
    Pestronk A; Choksi R; Blume G; Lopate G
    Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.
    Raine CS; Johnson AB; Marcus DM; Suzuki A; Bornstein MB
    J Neurol Sci; 1981 Oct; 52(1):117-31. PubMed ID: 6170737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.
    Boso F; Ruggero S; Giannotta C; Benedetti L; Marfia GA; Ermani M; Campagnolo M; Salvalaggio A; Gallia F; De Michelis C; Visentin A; Bianco M; Ruiz M; Mataluni G; Nobile-Orazio E; Briani C
    Eur J Neurol; 2017 Nov; 24(11):1334-1340. PubMed ID: 28782863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders.
    Rostami AM; Burns JB; Eccleston PA; Manning MC; Lisak RP; Silberberg DH
    Ann Neurol; 1987 Sep; 22(3):381-3. PubMed ID: 3674803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord lesions induced by antigalactocerebroside serum.
    Mastaglia FL; Carroll WM; Jennings AR
    Clin Exp Neurol; 1989; 26():33-44. PubMed ID: 2642138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of specific antibody-secreting cells in salivary glands of BALB/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae.
    Kusumoto Y; Ogawa T; Hamada S
    Arch Oral Biol; 1993 May; 38(5):361-7. PubMed ID: 8101076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nerve demyelination in rabbits after inoculation with Freund's complete adjuvant alone or in combination with lipid haptens.
    Mizisin AP; Wiley CA; Hughes RA; Powell HC
    J Neuroimmunol; 1987 Nov; 16(3):381-95. PubMed ID: 2444628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigens and experimental SLE induced by idiotypic dysregulation.
    Baharav E; Gur H; Fishman P; Ziporen L; Blank M; Aelion J; Kotb M; Shoenfeld Y
    Clin Exp Rheumatol; 1996; 14(4):359-66. PubMed ID: 8871833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoelectron microscopic characterization of galactocerebroside and nervous system antigen-1 (NS-1) positive oligodendrocytes in culture.
    Berg G; Schachner M
    Neurosci Lett; 1982 Jan; 28(1):75-80. PubMed ID: 7063144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cerebroside antibody levels in human visceral and cutaneous leishmaniasis, Trypanosoma rangeli infection, and chronic Chagas' disease.
    Avila JL; Rojas M
    Am J Trop Med Hyg; 1990 Jul; 43(1):52-60. PubMed ID: 2116736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.